3-(2-azaspiro[3.5]nonan-2-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(7-azaspiro[3.5]nonan-7-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(1H-1,2,4-triazol-5-yl)benzenesulfonamide;6-methyl-3-(4-piperidin-1-ylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]-1-piperidin-4-ylpiperidine

C104H141F3N36O12S6 — CID 159475200

IUPAC3-(2-azaspiro[3.5]nonan-2-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(7-azaspiro[3.5]nonan-7-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(1H-1,2,4-triazol-5-yl)benzenesulfonamide;6-methyl-3-(4-piperidin-1-ylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]-1-piperidin-4-ylpiperidine
SMILESCS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CCN(C4CCNCC4)CC3)cc2)c1-c1nn[nH]n1.Cc1ccc(N(C)C)c(-c2ncn[nH]2)c1S(N)(=O)=O.Cc1ccc(N2CC3(CCCCC3)C2)c(-c2nn[nH]n2)c1S(N)(=O)=O.Cc1ccc(N2CCC(N3CCCCC3)CC2)c(-c2nn[nH]n2)c1S(N)(=O)=O.Cc1ccc(N2CCC3(CCC3)CC2)c(-c2nn[nH]n2)c1S(N)(=O)=O.Cc1ccc(N2CCC3(CCCCC3)CC2)c(-c2nn[nH]n2)c1S(N)(=O)=O
InChIInChI=1S/C25H29F3N6O2S.C18H27N7O2S.C18H26N6O2S.2C16H22N6O2S.C11H15N5O2S/c1-37(35,36)23-21(25(26,27)28)7-6-20(22(23)24-30-32-33-31-24)18-4-2-16(3-5-18)17-10-14-34(15-11-17)19-8-12-29-13-9-19;1-13-5-6-15(16(17(13)28(19,26)27)18-20-22-23-21-18)25-11-7-14(8-12-25)24-9-3-2-4-10-24;1-13-5-6-14(15(16(13)27(19,25)26)17-20-22-23-21-17)24-11-9-18(10-12-24)7-3-2-4-8-18;1-11-3-4-12(22-9-7-16(8-10-22)5-2-6-16)13(14(11)25(17,23)24)15-18-20-21-19-15;1-11-5-6-12(22-9-16(10-22)7-3-2-4-8-16)13(14(11)25(17,23)24)15-18-20-21-19-15;1-7-4-5-8(16(2)3)9(10(7)19(12,17)18)11-13-6-14-15-11/h2-7,17,19,29H,8-15H2,1H3,(H,30,31,32,33);5-6,14H,2-4,7-12H2,1H3,(H2,19,26,27)(H,20,21,22,23);5-6H,2-4,7-12H2,1H3,(H2,19,25,26)(H,20,21,22,23);3-4H,2,5-10H2,1H3,(H2,17,23,24)(H,18,19,20,21);5-6H,2-4,7-10H2,1H3,(H2,17,23,24)(H,18,19,20,21);4-6H,1-3H3,(H2,12,17,18)(H,13,14,15)
InChIKeyLWHGWHSCAZRVAY-UHFFFAOYSA-N
MW2336.91 g/mol
LogP11.22
Rot. Bonds21

About 3-(2-azaspiro[3.5]nonan-2-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(7-azaspiro[3.5]nonan-7-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(1H-1,2,4-triazol-5-yl)benzenesulfonamide;6-methyl-3-(4-piperidin-1-ylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]-1-piperidin-4-ylpiperidine

3-(2-azaspiro[3.5]nonan-2-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(7-azaspiro[3.5]nonan-7-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(1H-1,2,4-triazol-5-yl)benzenesulfonamide;6-methyl-3-(4-piperidin-1-ylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]-1-piperidin-4-ylpiperidine (PubChem CID 159475200) has the molecular formula C104H141F3N36O12S6 and a molecular weight of 2336.91 g/mol. Its IUPAC name is 3-(2-azaspiro[3.5]nonan-2-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(7-azaspiro[3.5]nonan-7-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(1H-1,2,4-triazol-5-yl)benzenesulfonamide;6-methyl-3-(4-piperidin-1-ylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]-1-piperidin-4-ylpiperidine.

Molecular Properties

Compound Name3-(2-azaspiro[3.5]nonan-2-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(7-azaspiro[3.5]nonan-7-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(1H-1,2,4-triazol-5-yl)benzenesulfonamide;6-methyl-3-(4-piperidin-1-ylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]-1-piperidin-4-ylpiperidine
PubChem CID159475200
Molecular FormulaC104H141F3N36O12S6
Molecular Weight2336.91 g/mol
Exact Mass2334.98
IUPAC Name3-(2-azaspiro[3.5]nonan-2-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(7-azaspiro[3.5]nonan-7-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(1H-1,2,4-triazol-5-yl)benzenesulfonamide;6-methyl-3-(4-piperidin-1-ylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]-1-piperidin-4-ylpiperidine
SMILESCS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CCN(C4CCNCC4)CC3)cc2)c1-c1nn[nH]n1.Cc1ccc(N(C)C)c(-c2ncn[nH]2)c1S(N)(=O)=O.Cc1ccc(N2CC3(CCCCC3)C2)c(-c2nn[nH]n2)c1S(N)(=O)=O.Cc1ccc(N2CCC(N3CCCCC3)CC2)c(-c2nn[nH]n2)c1S(N)(=O)=O.Cc1ccc(N2CCC3(CCC3)CC2)c(-c2nn[nH]n2)c1S(N)(=O)=O.Cc1ccc(N2CCC3(CCCCC3)CC2)c(-c2nn[nH]n2)c1S(N)(=O)=O
InChIInChI=1S/C25H29F3N6O2S.C18H27N7O2S.C18H26N6O2S.2C16H22N6O2S.C11H15N5O2S/c1-37(35,36)23-21(25(26,27)28)7-6-20(22(23)24-30-32-33-31-24)18-4-2-16(3-5-18)17-10-14-34(15-11-17)19-8-12-29-13-9-19;1-13-5-6-15(16(17(13)28(19,26)27)18-20-22-23-21-18)25-11-7-14(8-12-25)24-9-3-2-4-10-24;1-13-5-6-14(15(16(13)27(19,25)26)17-20-22-23-21-17)24-11-9-18(10-12-24)7-3-2-4-8-18;1-11-3-4-12(22-9-7-16(8-10-22)5-2-6-16)13(14(11)25(17,23)24)15-18-20-21-19-15;1-11-5-6-12(22-9-16(10-22)7-3-2-4-8-16)13(14(11)25(17,23)24)15-18-20-21-19-15;1-7-4-5-8(16(2)3)9(10(7)19(12,17)18)11-13-6-14-15-11/h2-7,17,19,29H,8-15H2,1H3,(H,30,31,32,33);5-6,14H,2-4,7-12H2,1H3,(H2,19,26,27)(H,20,21,22,23);5-6H,2-4,7-12H2,1H3,(H2,19,25,26)(H,20,21,22,23);3-4H,2,5-10H2,1H3,(H2,17,23,24)(H,18,19,20,21);5-6H,2-4,7-10H2,1H3,(H2,17,23,24)(H,18,19,20,21);4-6H,1-3H3,(H2,12,17,18)(H,13,14,15)
InChIKeyLWHGWHSCAZRVAY-UHFFFAOYSA-N
XLogP11.22
TPSA683.52 Ų
H-Bond Donors12
H-Bond Acceptors37
Rotatable Bonds21
Heavy Atoms161
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002336.91
LogP ≤ 511.22
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1037

Analyze 3-(2-azaspiro[3.5]nonan-2-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(7-azaspiro[3.5]nonan-7-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(1H-1,2,4-triazol-5-yl)benzenesulfonamide;6-methyl-3-(4-piperidin-1-ylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]-1-piperidin-4-ylpiperidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-(2-amino-3H-benzimidazol-5-yl)-6-(cyclohexylmethyl)-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide;3-(2-amino-1H-benzimidazol-4-yl)-6-(piperidin-4-ylmethyl)-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide;4-[3-(aminomethyl)-4-methyl-2-(4H-triazol-5-yl)phenyl]cyclohexan-1-amine;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;1-(azetidin-3-ylmethyl)-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]piperidine;3-[4-(azetidin-3-yl)phenyl]-6-(piperidin-4-ylmethyl)-2-(2H-tetrazol-5-yl)benzenesulfonamide
CID 158690061
3-[3-(1-aminoethenyl)-3,9-diazaspiro[5.5]undecan-9-yl]-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;bis(4-[3-(aminomethyl)-4-methyl-2-(4H-triazol-5-yl)phenyl]cyclohexan-1-amine);5-[2-methylsulfonyl-6-[4-[1-(pyrrolidin-3-ylmethyl)azetidin-3-yl]phenyl]-3-(trifluoromethyl)phenyl]-2H-tetrazole;4-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]butan-1-amine;[1-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]piperidin-4-yl]methanamine
CID 159044584
3-(4-cyclohexylpiperidin-1-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;5-[6-[(1-cyclopentylcyclopropyl)methyl]-2-methylsulfonyl-3-(trifluoromethyl)phenyl]-2H-tetrazole;6-methyl-3-(4-methylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;8-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,8-diazaspiro[4.5]decane;9-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,9-diazaspiro[5.5]undecane;4-[1-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrrolidin-3-yl]piperidine
CID 161244117
9-[4-methyl-3-sulfamoyl-2-(2H-tetrazol-5-yl)phenyl]-3-azaspiro[5.5]undecane-3-carboximidamide;2-[4-[4-methyl-3-sulfamoyl-2-(2H-tetrazol-5-yl)phenyl]cyclohexyl]guanidine;4-[4-[4-methyl-3-sulfamoyl-2-(2H-tetrazol-5-yl)phenyl]cyclohexyl]piperidine-1-carboximidamide;9-[4-methyl-3-sulfamoyl-2-(2H-tetrazol-5-yl)phenyl]-3,9-diazaspiro[5.5]undecane-3-carboximidamide;2-[1-[4-methyl-3-sulfamoyl-2-(2H-tetrazol-5-yl)phenyl]piperidin-4-yl]guanidine
CID 159339736
3-[3-(1-aminoethenyl)-3,9-diazaspiro[5.5]undecan-9-yl]-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-[4-[1-(1-aminoethenyl)piperidin-4-yl]piperidin-1-yl]-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-[4-(3-aminopropyl)cyclohexyl]-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;N'-[4-[4-methyl-3-sulfamoyl-2-(2H-tetrazol-5-yl)phenyl]cyclohexyl]ethanimidamide;N'-[1-[4-methyl-3-sulfamoyl-2-(2H-tetrazol-5-yl)phenyl]piperidin-4-yl]ethanimidamide
CID 161685789

Frequently Asked Questions

What is the IUPAC name of 3-(2-azaspiro[3.5]nonan-2-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(7-azaspiro[3.5]nonan-7-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(1H-1,2,4-triazol-5-yl)benzenesulfonamide;6-methyl-3-(4-piperidin-1-ylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]-1-piperidin-4-ylpiperidine?
The IUPAC name of 3-(2-azaspiro[3.5]nonan-2-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(7-azaspiro[3.5]nonan-7-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(1H-1,2,4-triazol-5-yl)benzenesulfonamide;6-methyl-3-(4-piperidin-1-ylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]-1-piperidin-4-ylpiperidine (CID 159475200) is 3-(2-azaspiro[3.5]nonan-2-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(7-azaspiro[3.5]nonan-7-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(1H-1,2,4-triazol-5-yl)benzenesulfonamide;6-methyl-3-(4-piperidin-1-ylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]-1-piperidin-4-ylpiperidine.
What is the SMILES notation for 3-(2-azaspiro[3.5]nonan-2-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(7-azaspiro[3.5]nonan-7-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(1H-1,2,4-triazol-5-yl)benzenesulfonamide;6-methyl-3-(4-piperidin-1-ylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]-1-piperidin-4-ylpiperidine?
The canonical SMILES for 3-(2-azaspiro[3.5]nonan-2-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(7-azaspiro[3.5]nonan-7-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(1H-1,2,4-triazol-5-yl)benzenesulfonamide;6-methyl-3-(4-piperidin-1-ylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]-1-piperidin-4-ylpiperidine is CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CCN(C4CCNCC4)CC3)cc2)c1-c1nn[nH]n1.Cc1ccc(N(C)C)c(-c2ncn[nH]2)c1S(N)(=O)=O.Cc1ccc(N2CC3(CCCCC3)C2)c(-c2nn[nH]n2)c1S(N)(=O)=O.Cc1ccc(N2CCC(N3CCCCC3)CC2)c(-c2nn[nH]n2)c1S(N)(=O)=O.Cc1ccc(N2CCC3(CCC3)CC2)c(-c2nn[nH]n2)c1S(N)(=O)=O.Cc1ccc(N2CCC3(CCCCC3)CC2)c(-c2nn[nH]n2)c1S(N)(=O)=O.
What is the InChIKey of 3-(2-azaspiro[3.5]nonan-2-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(7-azaspiro[3.5]nonan-7-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(1H-1,2,4-triazol-5-yl)benzenesulfonamide;6-methyl-3-(4-piperidin-1-ylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]-1-piperidin-4-ylpiperidine?
The InChIKey is LWHGWHSCAZRVAY-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H29F3N6O2S.C18H27N7O2S.C18H26N6O2S.2C16H22N6O2S.C11H15N5O2S/c1-37(35,36)23-21(25(26,27)28)7-6-20(22(23)24-30-32-33-31-24)18-4-2-16(3-5-18)17-10-14-34(15-11-17)19-8-12-29-13-9-19;1-13-5-6-15(16(17(13)28(19,26)27)18-20-22-23-21-18)25-11-7-14(8-12-25)24-9-3-2-4-10-24;1-13-5-6-14(15(16(13)27(19,25)26)17-20-22-23-21-17)24-11-9-18(10-12-24)7-3-2-4-8-18;1-11-3-4-12(22-9-7-16(8-10-22)5-2-6-16)13(14(11)25(17,23)24)15-18-20-21-19-15;1-11-5-6-12(22-9-16(10-22)7-3-2-4-8-16)13(14(11)25(17,23)24)15-18-20-21-19-15;1-7-4-5-8(16(2)3)9(10(7)19(12,17)18)11-13-6-14-15-11/h2-7,17,19,29H,8-15H2,1H3,(H,30,31,32,33);5-6,14H,2-4,7-12H2,1H3,(H2,19,26,27)(H,20,21,22,23);5-6H,2-4,7-12H2,1H3,(H2,19,25,26)(H,20,21,22,23);3-4H,2,5-10H2,1H3,(H2,17,23,24)(H,18,19,20,21);5-6H,2-4,7-10H2,1H3,(H2,17,23,24)(H,18,19,20,21);4-6H,1-3H3,(H2,12,17,18)(H,13,14,15).
What are the key properties of 3-(2-azaspiro[3.5]nonan-2-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(7-azaspiro[3.5]nonan-7-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(1H-1,2,4-triazol-5-yl)benzenesulfonamide;6-methyl-3-(4-piperidin-1-ylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]-1-piperidin-4-ylpiperidine?
3-(2-azaspiro[3.5]nonan-2-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(7-azaspiro[3.5]nonan-7-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(1H-1,2,4-triazol-5-yl)benzenesulfonamide;6-methyl-3-(4-piperidin-1-ylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]-1-piperidin-4-ylpiperidine has a molecular weight of 2336.91 g/mol, XLogP of 11.22, 21 rotatable bonds, 12 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(2-azaspiro[3.5]nonan-2-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(7-azaspiro[3.5]nonan-7-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(1H-1,2,4-triazol-5-yl)benzenesulfonamide;6-methyl-3-(4-piperidin-1-ylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]-1-piperidin-4-ylpiperidine is sourced from PubChem (CID 159475200), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).